These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2110777)

  • 21. The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia.
    Waldmann TA; Strober W; Mogielnicki RP
    J Clin Invest; 1972 Aug; 51(8):2162-74. PubMed ID: 5054468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible pathogenetic role of low-molecular-weight proteins in Balkan nephropathy.
    Batuman V
    Kidney Int Suppl; 1991 Nov; 34():S89-92. PubMed ID: 1762343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of glycation of albumin on its binding to renal brush-border membrane vesicles: influence of aging in rats.
    Verbeke P; Perichon M; Schaeverbeke J; Bakala H
    Biochim Biophys Acta; 1996 Jun; 1282(1):93-100. PubMed ID: 8679665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II-binding sites in rat and primate isolated renal tubular basolateral membranes.
    Brown GP; Douglas JG
    Endocrinology; 1983 Jun; 112(6):2007-14. PubMed ID: 6303754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II binding sites on isolated rat renal brush border membranes.
    Brown GP; Douglas JG
    Endocrinology; 1982 Dec; 111(6):1830-6. PubMed ID: 6814893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of aminoglycoside antibiotics on chicken cystatin binding to renal brush-border membranes.
    Konopska B; Gburek J; Gołąb K; Warwas M
    J Pharm Pharmacol; 2013 Jul; 65(7):988-94. PubMed ID: 23738726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free light chains of immunoglobulins in normal serum and urine determined by radioimmunoassay.
    Sölling K
    Scand J Clin Lab Invest; 1975 Sep; 35(5):407-12. PubMed ID: 810881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [M-component of serum formed by lambda-type Bence-Jones protein].
    Snigurowicz J; Rostkowska J; Powiertowska-Rezmer M
    Acta Haematol Pol; 1976; 7(2):103-9. PubMed ID: 820159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of myeloma light chains on phosphate and glucose transport in renal proximal tubule cells.
    Batuman V; Guan S; O'Donovan R; Puschett JB
    Ren Physiol Biochem; 1994; 17(6):294-300. PubMed ID: 7533308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatic and renal deposits of kappa light chains revealing a dysglobulinemia (author's transl)].
    Mignon F; Morel-Maroger L; Cerf M; Preud'homme JL; Richet G
    Nephrologie; 1980; 1(4):167-70. PubMed ID: 6795518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of beta-lactam antibiotics with H+/peptide cotransporters in rat renal brush-border membranes.
    Takahashi K; Nakamura N; Terada T; Okano T; Futami T; Saito H; Inui KI
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1037-42. PubMed ID: 9694966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of glycated ovocystatin to rat renal brush border membranes.
    Golab K; Gburek J; Konopska B; Krotkiewski H; Warwas M
    Anim Sci J; 2013 Oct; 84(10):702-7. PubMed ID: 23607457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bence Jones proteins bind to a common peptide segment of Tamm-Horsfall glycoprotein to promote heterotypic aggregation.
    Huang ZQ; Kirk KA; Connelly KG; Sanders PW
    J Clin Invest; 1993 Dec; 92(6):2975-83. PubMed ID: 8254051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human autoantibody silencing by immunoglobulin light chains.
    Wardemann H; Hammersen J; Nussenzweig MC
    J Exp Med; 2004 Jul; 200(2):191-9. PubMed ID: 15263026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nodular glomerulopathy associated with nonamyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis.
    Gallo GR; Feiner HD; Katz LA; Feldman GM; Correa EB; Chuba JV; Buxbaum JN
    Am J Pathol; 1980 Jun; 99(3):621-44. PubMed ID: 6770693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lambda light chain deposition disease in a renal allograft.
    Tanenbaum ND; Howell DN; Middleton JP; Spurney RF
    Transplant Proc; 2005 Dec; 37(10):4289-92. PubMed ID: 16387099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular and tubular handling of differently charged human immunoglobulin light chains by the rat kidney.
    Baylis C; Falconer-Smith J; Ross B
    Clin Sci (Lond); 1988 Jun; 74(6):639-44. PubMed ID: 3135143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells.
    Pote A; Zwizinski C; Simon EE; Meleg-Smith S; Batuman V
    Am J Kidney Dis; 2000 Oct; 36(4):735-44. PubMed ID: 11007675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proximal tubular injury in myeloma.
    Batuman V
    Contrib Nephrol; 2007; 153():87-104. PubMed ID: 17075225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal granular monoclonal light chain deposits: morphological aspects in 11 cases.
    Noel LH; Droz D; Ganeval D; Grunfeld JP
    Clin Nephrol; 1984 May; 21(5):263-9. PubMed ID: 6428790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.